According to literature analysis, MYOD1-converted urine-derived cells are a novel DMD muscle cell model used to evaluate exon-skipping drugs targeting Dystrophin exons, including 44, 50, 51, and 55, which shows that there is a link between the MYOD1 gene and Dystrophin, enabling MYOD1 to be used as a tool to study DMD and evaluate potential treatments24, including the identified lncRNA. The gene discussed is MYOD1; the disease is Duchenne muscular dystrophy.